The label: no dry-mouth entry, but a fluid warning
Foundayo™ is a once-daily orforglipron tablet, a GLP-1 receptor agonist whose label does not call it a peptide [1]. Dry mouth is not among its listed reactions. The relevant warning is section 5.4: kidney injury, sometimes needing dialysis, has been reported with GLP-1 receptor agonists and with Foundayo™, mostly in people who became dehydrated after nausea, vomiting or diarrhoea [1]. The label asks prescribers to monitor kidney function in people with such reactions, especially when starting and raising the dose [1].
| Source | Entry | Comparison |
|---|---|---|
| US Prescribing Information, section 6.1 [1] | Acute kidney injury 0.2% | Placebo 0.05% (Trials 1 and 2) |
| US Prescribing Information, section 6.1 [1] | Dysgeusia 0.9%; dry mouth not listed | Placebo 0.3% |
| US Medication Guide [2] | Drink fluids to lower the chance of dehydration | Report nausea, vomiting or diarrhoea that does not go away |
| European Medicines Agency [3] | Positive CHMP opinion of 15 October 2026; no EMA product information available yet | No section 4.8 data |
| Health Canada [4] | Not found in the Drug Product Database | No monograph |
What the registries recorded
The ATTAIN weight trials only posted events affecting at least 5% of a group, so dry mouth is not visible there. The trials below published every event. They used trial doses of orforglipron in type 2 diabetes, a condition MedlinePlus itself lists as a cause of dry mouth [10].
| Trial [source] | Comparison group | Orforglipron groups, low to high dose |
|---|---|---|
| ACHIEVE-1, double blind [5] | Placebo: dry mouth 0, dehydration 0 of 138 | Dry mouth 0, 1, 1; thirst 0, 1, 0; dehydration 1, 0, 1, plus 1 serious case on 12 mg |
| ACHIEVE-5, double blind [7] | Placebo: dry mouth 0 of 140 | Dry mouth 0, 1, 0; thirst 1, 0, 0; dehydration 0, 0, 1 |
| ACHIEVE-2, open label [6] | Dapagliflozin: dry mouth 1 of 240 | Dry mouth 1, 0, 1; dehydration 0, 0, 2 |
| ACHIEVE-J, no comparator [8] | None | Dry mouth 1 of 132 on the lowest dose; dehydration 0, 1, 1 |
Reading the registry entries
- Dry mouth was rare everywhere, at most one person per group of 130 to 240, and dapagliflozin had a case too [6].
- Dehydration entries were also few, but they appeared on orforglipron and not on placebo in the two double-blind trials [5][7], which fits the direction of the label’s kidney warning.
- Some dehydration events were classed as serious: one in ACHIEVE-1 and one in the ATTAIN-2 weight trial, both on orforglipron [5][11].
- Counts this small cannot give a rate, only a sense that dry mouth is uncommon and that fluid loss is the effect to watch.
How Foundayo™ might leave your mouth dry
Most clearly supported: fluid loss. Nausea, vomiting and diarrhoea affected a large share of people on Foundayo™ in the trials, more so during dose escalation [1]. MedlinePlus lists not drinking enough because you feel sick or nauseated as a cause of dehydration, and a dry or sticky mouth as a sign [9].
Plausible, not measured: eating and drinking less overall. The label says Foundayo™ lowers food intake through reduced appetite [1], and food and drinks are part of daily fluid intake, but no Foundayo™ study measured fluid intake or saliva.
Related, not the same: dysgeusia, a distorted taste, affected 0.9% on the tablet [1]. MedlinePlus lists trouble tasting among symptoms of dry mouth [10], so the two can feel linked.
Other common causes
MedlinePlus and NIDCR list many reasons the mouth becomes dry [10][12]:
- Medicines, especially some for high blood pressure, depression and bladder control; hundreds of medicines can reduce saliva.
- Diabetes, Sjögren’s disease and HIV.
- Radiation to the head and neck, chemotherapy and immunotherapy.
- Nerve damage from a head or neck injury.
- Breathing through the mouth, and alcohol, tobacco and other substances.
- Nervousness or stress, which can dry the mouth for a while in anyone.
What general sources suggest
MedlinePlus suggests drinking plenty of water, limiting caffeine, chewing sugarless gum or sucking sugarless sweets to stimulate saliva, avoiding spicy and salty foods, avoiding alcohol and tobacco, using a humidifier at night and choosing a mouthwash made for dry mouth [10]. Because saliva protects teeth, it advises brushing and flossing and seeing a dentist regularly [10].
NIDCR says dry mouth is not a normal part of ageing and that anyone who thinks they have it should see a dentist or doctor to find out why [12]. If a medicine is the cause, MedlinePlus notes that a provider or dentist may suggest changing the dose or the medicine [10]; that is a decision to make with them, not alone.
For the stomach side effects themselves, the Medication Guide asks you to drink fluids and to tell your provider right away about nausea, vomiting or diarrhoea that does not go away [2].
Points specific to Foundayo™
The label pairs the dehydration warning with the start of treatment and each dose increase [1]. Foundayo™ is raised no sooner than every 30 days [1], so the first days after a step are a sensible time to pay attention to thirst, urine colour and how often you drink.
Foundayo™ can be taken with or without food [1], which means a meal is not needed to take it. Pairing the daily tablet with a glass of water is a habit some people find useful, though the label sets no rule about water.
Foundayo™ is a trademark of Eli Lilly and Company. PepLabo is not affiliated with or endorsed by Eli Lilly and Company.
When to get help
The signs and contact information below come from this article’s sourced guidance.
Emergency
- Confusion, fainting or unusual drowsiness in someone who has been vomiting or has diarrhoea
Contact: Emergency services
MedlinePlus [9]